Philip Morris International Short-Term Borrowings increased by 3288.7% to $5.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.3%, from $4.44B to $5.69B. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows a downward trend with a -7.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $136.00M | $223.00M | $225.00M | $2.44B | $1.56B | $2.82B | $5.64B | $4.80B | $4.12B | $2.15B | $1.97B | $279.00M | $139.00M | $152.00M | $137.00M | $4.44B | $2.54B | $1.88B | $168.00M | $5.69B |
| QoQ Change | — | +64.0% | +0.9% | +984.9% | -36.2% | +80.9% | +100.0% | -14.8% | -14.2% | -47.9% | -8.4% | -85.8% | -50.2% | +9.4% | -9.9% | >999% | -42.8% | -26.0% | -91.1% | >999% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +96.8% | +164.5% | -23.7% | -65.1% | -94.2% | -96.6% | -92.9% | -93.0% | >999% | >999% | >999% | +22.6% | +28.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.